---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-004736"
form_type: "8-K"
ticker: "QETA"
cik: "0001978528"
company_name: "Quetta Acquisition Corp"
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:52:57.559968+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Quetta Acquisition Corp enters LOI with clinical-stage therapeutics target; deadline extended to Jan 2025

## Summary
- Entered non-binding LOI with a clinical-stage therapeutics company for a potential business combination.
- Deadline to complete initial business combination automatically extended to January 11, 2025 due to LOI.
- LOI is non-binding; no definitive agreement exists and no terms disclosed.
- Target is a clinical-stage therapeutics company; name and valuation not provided.

## SEC filing metadata
- accession: 0001829126-24-004736
- form_type: 8-K
- ticker: QETA
- cik: 0001978528
- company_name: Quetta Acquisition Corp
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1978528/000182912624004736/0001829126-24-004736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1978528/000182912624004736/quettaacquisition_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-004736
- JSON: https://secwatch.observer/filing/0001829126-24-004736.json
- Plain text: https://secwatch.observer/filing/0001829126-24-004736.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.